Putting “One and Done” in the Rearview Mirror

Clinical Researcher—June 2018 (Volume 32, Issue 6) EXECUTIVE DIRECTOR’S MESSAGE Jim Kremidas [DOI: 10.14524/CR-18-4034]     It’s called the “one and done” phenomena, and it’s a problem that has plagued the clinical trial industry for years. It refers to physicians and other medical professionals who are would-be principal investigators (PIs), though completely or relatively inexperienced […]

Spreading the Good News

Clinical Researcher—June 2018 (Volume 32, Issue 6) MANAGING EDITOR’S MESSAGE Gary W. Cramer [DOI: 10.14524/CR-18-4035]     In one of my previous lives, I spent the better part of 15 years writing enough press releases about the findings of faculty and student research projects for a major university that you could have lined them up […]

ACRP 2018 Attendees Discuss Emerging Trends in Clinical Research

5 Clinical Research Trends Emerge at ACRP 2018

Whether it was during a session, a specialized workshop, or a networking break, several interesting themes dominated the Association of Clinical Research Professionals (ACRP) 2018 annual conference held at the Gaylord National Resort & Convention Center in National Harbor, Md., in April. Here’s a closer look at five key takeaways.

#1—Professional Competency is […]

A PMG 'Research Heroes' Team Member

Site Woos New Trial Participants with Innovative Outreach

Looking for a way to raise awareness of clinical trials in your region and collect the names of people actively interested in trial participation? The folks at PMG Research in Winston-Salem, N.C. have two words for you: food trucks. In April, after initially planning on its own smaller, standalone event, PMG piggybacked onto the city’s […]

Foundation and ClinicalTrials.gov Extol Virtues of Expanded Access for Patients

Public-private partnerships have the flexibility to increase patient equity in accessing investigational therapies and to create a neutral clearinghouse for educational and technical resources, says June Wasser, MA, executive director of the Reagan-Udall Foundation (RUF) for the Food and Drug Administration (FDA). RUF was created by Congress in 2007 as an independent organization designed in […]